134 related articles for article (PubMed ID: 31568068)
1. Catechol-O-methyltransferase gene expression in stress-induced and non-stress induced schizophrenia.
Aghamaleki-Sarvestani Z; Vousooghi N; Tabrizi M; Alipour ME; Alaghband-Rad J; Mostafavi-Abdolmaleky H; Zarindast MR
Psychiatr Genet; 2020 Feb; 30(1):10-18. PubMed ID: 31568068
[TBL] [Abstract][Full Text] [Related]
2. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic pathway gene polymorphisms and genetic susceptibility to schizophrenia among north Indians.
Srivastava V; Deshpande SN; Thelma BK
Neuropsychobiology; 2010; 61(2):64-70. PubMed ID: 20016224
[TBL] [Abstract][Full Text] [Related]
4. Catechol-o-methyltransferase polymorphism and susceptibility to major depressive disorder modulates psychological stress response.
Jabbi M; Kema IP; van der Pompe G; te Meerman GJ; Ormel J; den Boer JA
Psychiatr Genet; 2007 Jun; 17(3):183-93. PubMed ID: 17417063
[TBL] [Abstract][Full Text] [Related]
5. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.
Goldberg TE; Egan MF; Gscheidle T; Coppola R; Weickert T; Kolachana BS; Goldman D; Weinberger DR
Arch Gen Psychiatry; 2003 Sep; 60(9):889-96. PubMed ID: 12963670
[TBL] [Abstract][Full Text] [Related]
6. Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia.
Illi A; Mattila KM; Kampman O; Anttila S; Roivas M; Lehtimäki T; Leinonen E
J Clin Psychopharmacol; 2003 Oct; 23(5):429-34. PubMed ID: 14520117
[TBL] [Abstract][Full Text] [Related]
7. Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls.
Matsuzaka CT; Christofolini D; Ota VK; Gadelha A; Berberian AA; Noto C; Mazzotti DR; Spindola LM; Moretti PN; Smith MAC; Melaragno MI; Belangero SI; Bressan RA
Braz J Psychiatry; 2017; 39(4):302-308. PubMed ID: 28273278
[TBL] [Abstract][Full Text] [Related]
8. Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions.
Lewandowski KE
Harv Rev Psychiatry; 2007; 15(5):233-44. PubMed ID: 17924258
[TBL] [Abstract][Full Text] [Related]
9. Genetic combination risk for schizophrenia.
Oishi K; Niitsu T; Kanahara N; Hashimoto T; Komatsu H; Sasaki T; Takase M; Sato Y; Iyo M
Schizophr Res; 2020 Jan; 215():473-474. PubMed ID: 31477374
[No Abstract] [Full Text] [Related]
10. Association study between the rs165599 catechol-O-methyltransferase genetic polymorphism and schizophrenia in a Brazilian sample.
Cordeiro Q; Silva RT; Vallada H
Arq Neuropsiquiatr; 2012 Dec; 70(12):913-6. PubMed ID: 23295417
[TBL] [Abstract][Full Text] [Related]
11. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia.
Nicodemus KK; Kolachana BS; Vakkalanka R; Straub RE; Giegling I; Egan MF; Rujescu D; Weinberger DR
Hum Genet; 2007 Feb; 120(6):889-906. PubMed ID: 17006672
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.
Sazci A; Ergul E; Kucukali I; Kilic G; Kaya G; Kara I
Brain Res Mol Brain Res; 2004 Dec; 132(1):51-6. PubMed ID: 15548428
[TBL] [Abstract][Full Text] [Related]
13. A novel protein isoform of catechol O-methyltransferase (COMT): brain expression analysis in schizophrenia and bipolar disorder and effect of Val158Met genotype.
Tunbridge EM; Weinberger DR; Harrison PJ
Mol Psychiatry; 2006 Feb; 11(2):116-7. PubMed ID: 16247488
[No Abstract] [Full Text] [Related]
14. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J
Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704
[TBL] [Abstract][Full Text] [Related]
15. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
[TBL] [Abstract][Full Text] [Related]
16. Catechol O-methyltransferase polymorphism and eye tracking in schizophrenia: a preliminary report.
Thaker GK; Wonodi I; Avila MT; Hong LE; Stine OC
Am J Psychiatry; 2004 Dec; 161(12):2320-2. PubMed ID: 15569909
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.
Apud JA; Weinberger DR
CNS Drugs; 2007; 21(7):535-57. PubMed ID: 17579498
[TBL] [Abstract][Full Text] [Related]
18. Further tests of the association between schizophrenia and single nucleotide polymorphism markers at the catechol-O-methyltransferase locus in an Askenazi Jewish population using microsatellite markers.
Horowitz A; Shifman S; Rivlin N; Pisanté A; Darvasi A
Psychiatr Genet; 2005 Sep; 15(3):163-9. PubMed ID: 16094249
[TBL] [Abstract][Full Text] [Related]
19. The relation of serotonin-related gene and COMT gene polymorphisms with criminal behavior in schizophrenic disorder.
Koh KB; Choi EH; Lee YJ; Han M; Choi SS; Kim SW; Lee MG
J Clin Psychiatry; 2012 Feb; 73(2):159-63. PubMed ID: 22053918
[TBL] [Abstract][Full Text] [Related]
20. COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
Shukla AA; Jha M; Birchfield T; Mukherjee S; Gleason K; Abdisalaam S; Asaithamby A; Adams-Huet B; Tamminga CA; Ghose S
Schizophr Res; 2016 May; 173(1-2):94-100. PubMed ID: 27021555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
